Ignyte Acquisition Corp. IGNY 深 沪
等待开盘 08-01 09:30:00 美东时间
13.05
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 13.05
- 总市值 9510.19万
- 52周最高 15.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.62
- 委 比 0.00%
- 总股本 728.75万
- 历史最高 15.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.62
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Replimune Faces Investor Lawsuit Over IGNYTE Trial
In a dramatic turn of events, Replimune Group, Inc. finds itself at the center ...
07-30 03:15
Iovance climbs after FDA rejection for Replimune’s skin cancer drug
The FDA’s decision to reject Replimune’s (NASDAQ:REPL) lead asset RP1 for a type of skin cancer known as melanoma appears to have boosted its rival, Iovance Biotherapeutics (NASDAQ:IOVA), whose lead p...
07-22 22:54
FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks
Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.
07-22 21:41
Adaptimmune targets $400M sarcoma franchise peak sales by 2027
Earnings Call Insights: Adaptimmune Therapeutics (ADAP) Q4 2024 Management View CEO Adrian Rawcliffe highlighted the accelerated progress of the TECELRA launch, emphasizing that the company has alread...
03-21 00:10
Replimune to raise ~$100M in private financing
Replimune Group (NASDAQ:REPL) said on Thursday it entered into a securities purchase agreement for a private investment in public equity ("PIPE"). The biotechnology company will issue and sell 5,668,9...
2024-06-13 21:47
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
U.S. stocks traded mixed toward the end of trading, with the S&P 500 fallin...
2024-06-07 02:45
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaini...
2024-06-07 00:22
Replimune up 30% on results for RP1 combo in melanoma
Replimune Group (NASDAQ:REPL) said that topline results of an analysis of a trial of RP1 plus Bristol-Myers Squibb's (BMY) Opdivo (nivolumab) in melanoma patients who failed on a PD-1 inhibitor indica...
2024-06-07 00:05
Replimune Group’s IGNYTE Trial Shows Promising Melanoma Outcomes
An update from Replimune Group (REPL) is now available. Replimune Group, Inc. h...
2024-06-06 22:03
Crude Oil Moves Lower; AutoZone Profit Tops Views
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500 also fell, dropping, 0.07% to 4,566.73.
2023-12-06 03:27
